Conagen Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • Debt - PPP

  • Financing Rounds
  • 3

  • Investments
  • 1

Conagen General Information

Description

Developer of bio-amazing synthetic biology solutions for food and beverage, nutrition and pharma industries. The company offers strain development, metabolic pathway engineering, fermentation process development, commercial-scale microbial fermentation, analytical and extraction chemistry and laboratory robotics and automation services, providing clients with the metabolic pathways of synthetic biology through specialized fermentation.

Contact Information

Website
www.conagen.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 15 DeAngelo Drive
  • Bedford, MA 01730
  • United States
+1 (781)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 15 DeAngelo Drive
  • Bedford, MA 01730
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Conagen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Conagen‘s full profile, request access.

Request a free trial

Conagen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bio-amazing synthetic biology solutions for food and beverage, nutrition and pharma industries. The company
Biotechnology
Bedford, MA
28 As of 2025

Lyngby, Denmark
 

Gainesville, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Conagen Competitors (9)

One of Conagen’s 9 competitors is Novonesis, a Corporation company based in Lyngby, Denmark.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novonesis Corporation Lyngby, Denmark
BioTork Venture Capital-Backed Gainesville, FL
DMC Biotechnologies Venture Capital-Backed Boulder, CO
GlycosBio Venture Capital-Backed Houston, TX
BellBrook Labs Venture Capital-Backed Madison, WI
You’re viewing 5 of 9 competitors. Get the full list »

Conagen Patents

Conagen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025137687-A2 Production of peptides using tandem repetitive recombination strategy Inactive 22-Dec-2023
WO-2025137687-A3 Production of peptides using tandem repetitive recombination strategy Inactive 22-Dec-2023
WO-2025030091-A2 Resveratrol production from recombinant host Inactive 02-Aug-2023
WO-2025030091-A3 Resveratrol production from recombinant host Inactive 02-Aug-2023
WO-2025030091-A8 Resveratrol production from recombinant host Inactive 02-Aug-2023 C12P7/22
To view Conagen’s complete patent history, request access »

Conagen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Conagen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Conagen‘s full profile, request access.

Request a free trial

Conagen Investments (1)

Conagen’s most recent deal was a Corporate Asset Purchase with Glycoproteins production platform. The deal was made on 21-Aug-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Glycoproteins production platform 21-Aug-2019 Corporate Asset Purchase Buildings and Property
To view Conagen’s complete investments history, request access »

Conagen FAQs

  • When was Conagen founded?

    Conagen was founded in 2010.

  • Where is Conagen headquartered?

    Conagen is headquartered in Bedford, MA.

  • What is the size of Conagen?

    Conagen has 28 total employees.

  • What industry is Conagen in?

    Conagen’s primary industry is Biotechnology.

  • Is Conagen a private or public company?

    Conagen is a Private company.

  • What is Conagen’s current revenue?

    The current revenue for Conagen is .

  • Who are Conagen’s investors?

    Sumitomo Chemical and Small Business Innovation Research and Small Business Technology Transfer Programs have invested in Conagen.

  • Who are Conagen’s competitors?

    Novonesis, BioTork, DMC Biotechnologies, GlycosBio, and BellBrook Labs are some of the 9 competitors of Conagen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process